Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05613556 · ClinicalTrials.gov registry record
Monitoring Physiologic Parameters in Individuals With Diabetic Peripheral Neuropathy
A clinical trial of Diabetic Foot and Diabetic Peripheral Neuropathy, sponsored by Orpyx Medical Technologies.
- Completed
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT05613556 is a study of Diabetic Foot and Diabetic Peripheral Neuropathy that has completed, run by Orpyx Medical Technologies. The registered enrollment target is 60 participants, below the 10,339-participant average among 30 other Diabetic Foot trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05613556, a study of Diabetic Foot and Diabetic Peripheral Neuropathy, has completed, sponsored by Orpyx Medical Technologies.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of this study is to use the Orpyx® SI Sensory Insole System (Orpyx Medical Technologies Inc., Calgary AB, Canada) ("Orpyx" or "the Company") as an adjunct to diabetic peripheral neuropathy standard of care (SOC), and observe step count, pressure, temperature, and adherence data through remote patient monitoring (RPM). This will provide insights into patient engagement and the benefits of offering remote, preventative care.
Conditions Studied
Interventions
- DEVICE Orpyx SI® Sensory Insole System
Study Locations (1)
Ohio
- WAFL Inc / Cutting Edge Research - Circleville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2023-04-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05613556
The ClinicalTrials.gov registry entry for NCT05613556 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 10,339-participant average among 30 other Diabetic Foot trials with a reported enrollment target (99% lower). The listed sponsor is Orpyx Medical Technologies, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diabetic Foot appearing as the primary indexed condition, and to 1 intervention - of which Orpyx SI® Sensory Insole System is the first listed.
NCT05613556 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05613556 about?
NCT05613556 is a clinical study titled "Monitoring Physiologic Parameters in Individuals With Diabetic Peripheral Neuropathy". The primary aim of this study is to use the Orpyx® SI Sensory Insole System (Orpyx Medical Technologies Inc., Calgary AB, Canada) ("Orpyx" or "the Company") as an adjunct to diabetic peripheral neuropathy standard of care (SOC), and observe step count, pressure, temperature, and adherence data throu...
What is the current status of trial NCT05613556?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2022-04-01. Estimated completion is 2023-04-28.
What conditions does trial NCT05613556 study?
This clinical trial studies the following conditions: Diabetic Foot, Diabetic Peripheral Neuropathy.
What interventions are being tested in trial NCT05613556?
The interventions under investigation include: Orpyx SI® Sensory Insole System (DEVICE).
Who is sponsoring clinical trial NCT05613556?
This trial is sponsored by Orpyx Medical Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05613556 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
RECRUITING
-
Effectiveness of Remote Foot Temperature Monitoring
RECRUITING · NA
-
A Real-World Registry of Chronic Wounds and Ulcers
RECRUITING
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
-
A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.